Tech Company M&A Transactions
Apoptos Acquisition
On 6/26/2009, Apoptos was bought by Receptos. What Receptos paid for Apoptos was not provided.
Transaction Overview
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10835 Rd. to the Cure 205
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Apoptos Inc. is focused on developing novel small molecule drug therapies that directly induce tumor cell apoptosis. Apoptos is pioneering its anticancer platforms in close collaborations with preeminent scientists in the fields of apoptosis and experimental cancer therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Rastetter
Co-Founder
Marcus Boehm
Co-Founder
Robert Peach
Browse more venture capital transactions:
Prev: 6/26/2009: Sense Networks venture capital transaction
Next: 6/26/2009: Ankeena Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs